Skip to main content
Premium Trial:

Request an Annual Quote

New Products: MLL's AML/MDS Panel; Adaptive Biotechnologies' ClonoSeq

Premium

Munich Leukemia Laboratory has developed a 31-gene sequencing panel to identify markers to sub-classify acute myeloid leukemia and myelodysplastic syndromes using RainDance enrichment technology and 2x250 base pair sequencing on the Illumina MiSeq.


Adaptive Biotechnologies has launched ClonoSeq, a next-generation sequencing-based assay to detect minimal residual disease in blood-based cancers. The assay will be available for widespread use by mid-2013, according to the company.

The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Sanction Violation Charges

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.